US Generics Market Poised for Stupendous Growth
Backed by factors like patent expiration of drugs and aging population, the US generics market will grow at a CAGR of 10% during 2010-2013, says RNCOS.

Our research revealed human insulin segment to offer a significant growth potential for generics players as diabetes prevalence is rapidly increasing and there are key drugs going off-patent in the near future. Humalog and Novolog are the key drugs whose patents are likely to get expired in 2014 and 2017, respectively. Moreover, the cost of insulin in the US is one the highest in the world and no generic version of drugs is available at present.
The report, "Booming US Generic Drug Market", illustrates the market potential for human insulin segment and covers detailed analysis on other related segments, such as lipid regulator, antipsychotics, angiotensin II receptor, anti-depressants, ppi etc. It also investigates the recent market trends and analyzes their impact on the market performance. These trends have been identified after an in-depth analysis of market developments and industry focus.
In short, the report is an outcome of an extensive research and prudent analysis of the US generics market that effectively evaluates past, present, and future market performance. The forecasts in the report make use of proper base and methods so that future outlook may be more realistic. Overall, the report is likely to provide clients with a significant insight into the US generics market.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM589.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm
About RNCOS:
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.
###
Tag Words:
generics market us
Categories: Health
Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707